Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-06

AUTHORS

V Chiarion-Sileni, M Guida, L Ridolfi, A Romanini, P Del Bianco, J Pigozzo, S Brugnara, G Colucci, R Ridolfi, G L De Salvo

ABSTRACT

BACKGROUND: This study compared the central nervous system (CNS) metastasis incidence between a temozolomide- and a dacarbazine-based regimen in untreated stage IV melanoma patients. METHODS: A total of 150 patients were randomly assigned to receive either oral temozolomide (200 mg m(-2) per day; days 1-5) or intravenous dacarbazine (800 mg m(-2); day 1), in combination with intravenous cisplatin (75 mg m(-2); day 1) and subcutaneous interleukin-2 (3 MU twice daily; days 9-18), every 28 days (CTI and CDI). RESULTS: A total of 149 patients were eligible for an intention-to-treat analysis (CTI: n=74, CDI: n=75). The 1-year cumulative CNS incidence failure was 20.6% for CTI and 31.1% for CDI (P=0.22). In all 24 patients in CTI (32%) and 34 (45%) in CDI developed CNS metastases; 31 patients died of early systemic progression, before CNS evaluation. Median survival time was 8.4 months in the CTI and 8.7 in the CDI arm; in patients with CNS metastases the median survival time was 13.5 months in the CTI and 11.5 in the CDI arm. No difference in toxicity was observed between the two arms. CONCLUSION: The incidence of CNS failures in metastatic melanoma was not significantly reduced and the clinical course was not modified substituting a dacarbazine-based regimen with a temozolomide-based regimen. Patients who developed CNS metastases did not have a worse prognosis than patients progressing in other sites and should not be excluded from new investigational studies. More... »

PAGES

1816

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2011.178

DOI

http://dx.doi.org/10.1038/bjc.2011.178

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001585610

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21610711


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood-Brain Barrier", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dacarbazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Melanoma and Skin Cancer Unit, Istituto Oncologico Veneto IOV \u2013 IRCCS, via Gattamelata 64, Padova 35128, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chiarion-Sileni", 
        "givenName": "V", 
        "id": "sg:person.0707113743.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707113743.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Istituto Oncologico, via Hahnemann 10, Bari 70126, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guida", 
        "givenName": "M", 
        "id": "sg:person.01340562667.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340562667.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Immunotherapy and Somatic Cell Therapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, via Maroncelli 40, Meldola FC 47014, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ridolfi", 
        "givenName": "L", 
        "id": "sg:person.01163341772.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163341772.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Medical Oncology Unit, S. Chiara Hospital, via Roma 67, Pisa 56100, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Romanini", 
        "givenName": "A", 
        "id": "sg:person.0764656474.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764656474.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Clinical Trials and Biostatistics Unit, Istituto Oncologico Veneto IOV \u2013 IRCCS, via Gattamelata 64, Padova 35128, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Del Bianco", 
        "givenName": "P", 
        "id": "sg:person.0707026774.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707026774.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Melanoma and Skin Cancer Unit, Istituto Oncologico Veneto IOV \u2013 IRCCS, via Gattamelata 64, Padova 35128, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pigozzo", 
        "givenName": "J", 
        "id": "sg:person.01076711104.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076711104.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Chiara", 
          "id": "https://www.grid.ac/institutes/grid.415176.0", 
          "name": [
            "Oncology Center, S. Chiara Hospital, Largo Medaglie d\u2019Oro 1, Trento 38100, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brugnara", 
        "givenName": "S", 
        "id": "sg:person.0666401714.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666401714.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Istituto Oncologico, via Hahnemann 10, Bari 70126, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Colucci", 
        "givenName": "G", 
        "id": "sg:person.0634153206.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634153206.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Immunotherapy and Somatic Cell Therapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, via Maroncelli 40, Meldola FC 47014, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ridolfi", 
        "givenName": "R", 
        "id": "sg:person.01050453536.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050453536.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Clinical Trials and Biostatistics Unit, Istituto Oncologico Veneto IOV \u2013 IRCCS, via Gattamelata 64, Padova 35128, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Salvo", 
        "givenName": "G L", 
        "id": "sg:person.0605217455.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605217455.41"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2006.10.0677", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000033623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.12.149", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001105110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008390-200204000-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004158366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008390-200204000-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004158366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cmr.0000195697.58013.b7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004821277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cmr.0000195697.58013.b7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004821277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cmr.0000195697.58013.b7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004821277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1214/aos/1176350951", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010369076"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cmr.0000183921.46031.93", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012826588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cmr.0000183921.46031.93", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012826588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cmr.0000183921.46031.93", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012826588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.coc.0000164006.72694.1b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016084043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.coc.0000164006.72694.1b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016084043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.coc.0000164006.72694.1b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016084043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.5791", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023297721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.11436", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030848636"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/38.9.1974900", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031461172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/38.9.1974900", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031461172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10147-008-0797-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037744453", 
          "https://doi.org/10.1007/s10147-008-0797-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10147-008-0797-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037744453", 
          "https://doi.org/10.1007/s10147-008-0797-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cmr.0000136711.75287.55", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042572950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cmr.0000136711.75287.55", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042572950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1179/joc.1995.7.3.224", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044813084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.12.0253", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044938860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi190", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050987641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cmr.0b013e3283350578", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053462375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cmr.0b013e3283350578", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053462375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cmr.0b013e3283350578", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053462375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.6.1600", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.07.044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074500170", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.7.2105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.1.158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074572226"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074669606", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.16.3635", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074864907"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075173462", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077278318", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077917465", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082952799", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-06", 
    "datePublishedReg": "2011-06-01", 
    "description": "BACKGROUND: This study compared the central nervous system (CNS) metastasis incidence between a temozolomide- and a dacarbazine-based regimen in untreated stage IV melanoma patients.\nMETHODS: A total of 150 patients were randomly assigned to receive either oral temozolomide (200 mg m(-2) per day; days 1-5) or intravenous dacarbazine (800 mg m(-2); day 1), in combination with intravenous cisplatin (75 mg m(-2); day 1) and subcutaneous interleukin-2 (3 MU twice daily; days 9-18), every 28 days (CTI and CDI).\nRESULTS: A total of 149 patients were eligible for an intention-to-treat analysis (CTI: n=74, CDI: n=75). The 1-year cumulative CNS incidence failure was 20.6% for CTI and 31.1% for CDI (P=0.22). In all 24 patients in CTI (32%) and 34 (45%) in CDI developed CNS metastases; 31 patients died of early systemic progression, before CNS evaluation. Median survival time was 8.4 months in the CTI and 8.7 in the CDI arm; in patients with CNS metastases the median survival time was 13.5 months in the CTI and 11.5 in the CDI arm. No difference in toxicity was observed between the two arms.\nCONCLUSION: The incidence of CNS failures in metastatic melanoma was not significantly reduced and the clinical course was not modified substituting a dacarbazine-based regimen with a temozolomide-based regimen. Patients who developed CNS metastases did not have a worse prognosis than patients progressing in other sites and should not be excluded from new investigational studies.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.2011.178", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "104"
      }
    ], 
    "name": "Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens", 
    "pagination": "1816", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "078da252aa71076760d36fb57d5eb0c389c32a72a98cd4524a80e104365348d4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21610711"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2011.178"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001585610"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2011.178", 
      "https://app.dimensions.ai/details/publication/pub.1001585610"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000436.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc2011178"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.178'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.178'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.178'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.178'


 

This table displays all metadata directly associated to this object as RDF triples.

270 TRIPLES      21 PREDICATES      68 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2011.178 schema:about N1956d2e1cb4e4299a2ba243887f14ef8
2 N267fd9375e3345e1a2a81593c93d3441
3 N29597efb10374118963ee880b1bef19e
4 N435c8b21c5da48b79dd5f263f6db2e9f
5 N45ef374832264848985d53acb676b54c
6 N5101bd1fcd5e4839a1f1e0ea4cbfac31
7 N543331d545ad461b9643a991c2bfb218
8 N5fac4af7e04c4e559996237fd72b280e
9 N822605b998b64ff4a4bb9b15001338a1
10 Nc9ce371b9d4e4c7680914f1c985e3568
11 Ncd49ebdfede2432d9f1fa3b3fceda7fa
12 Nd49fe60243984b28ae5f061841ae1a40
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Nad06d652ba344efb8b0ce310b2191989
16 schema:citation sg:pub.10.1007/s10147-008-0797-8
17 https://app.dimensions.ai/details/publication/pub.1074500170
18 https://app.dimensions.ai/details/publication/pub.1074669606
19 https://app.dimensions.ai/details/publication/pub.1075173462
20 https://app.dimensions.ai/details/publication/pub.1077278318
21 https://app.dimensions.ai/details/publication/pub.1077917465
22 https://app.dimensions.ai/details/publication/pub.1082952799
23 https://doi.org/10.1002/cncr.11436
24 https://doi.org/10.1093/annonc/mdi190
25 https://doi.org/10.1097/00008390-200204000-00011
26 https://doi.org/10.1097/01.cmr.0000136711.75287.55
27 https://doi.org/10.1097/01.cmr.0000183921.46031.93
28 https://doi.org/10.1097/01.cmr.0000195697.58013.b7
29 https://doi.org/10.1097/01.coc.0000164006.72694.1b
30 https://doi.org/10.1097/cmr.0b013e3283350578
31 https://doi.org/10.1177/38.9.1974900
32 https://doi.org/10.1179/joc.1995.7.3.224
33 https://doi.org/10.1200/jco.1999.17.7.2105
34 https://doi.org/10.1200/jco.20.6.1600
35 https://doi.org/10.1200/jco.2000.18.1.158
36 https://doi.org/10.1200/jco.2001.19.16.3635
37 https://doi.org/10.1200/jco.2002.07.044
38 https://doi.org/10.1200/jco.2004.12.149
39 https://doi.org/10.1200/jco.2005.02.5791
40 https://doi.org/10.1200/jco.2006.10.0677
41 https://doi.org/10.1200/jco.2007.12.0253
42 https://doi.org/10.1214/aos/1176350951
43 schema:datePublished 2011-06
44 schema:datePublishedReg 2011-06-01
45 schema:description BACKGROUND: This study compared the central nervous system (CNS) metastasis incidence between a temozolomide- and a dacarbazine-based regimen in untreated stage IV melanoma patients. METHODS: A total of 150 patients were randomly assigned to receive either oral temozolomide (200 mg m(-2) per day; days 1-5) or intravenous dacarbazine (800 mg m(-2); day 1), in combination with intravenous cisplatin (75 mg m(-2); day 1) and subcutaneous interleukin-2 (3 MU twice daily; days 9-18), every 28 days (CTI and CDI). RESULTS: A total of 149 patients were eligible for an intention-to-treat analysis (CTI: n=74, CDI: n=75). The 1-year cumulative CNS incidence failure was 20.6% for CTI and 31.1% for CDI (P=0.22). In all 24 patients in CTI (32%) and 34 (45%) in CDI developed CNS metastases; 31 patients died of early systemic progression, before CNS evaluation. Median survival time was 8.4 months in the CTI and 8.7 in the CDI arm; in patients with CNS metastases the median survival time was 13.5 months in the CTI and 11.5 in the CDI arm. No difference in toxicity was observed between the two arms. CONCLUSION: The incidence of CNS failures in metastatic melanoma was not significantly reduced and the clinical course was not modified substituting a dacarbazine-based regimen with a temozolomide-based regimen. Patients who developed CNS metastases did not have a worse prognosis than patients progressing in other sites and should not be excluded from new investigational studies.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree true
49 schema:isPartOf N1e7e78ce74404bd08daf9d39880065e8
50 Nb8b964febe61474f9b3ddfbb7cd6b039
51 sg:journal.1017082
52 schema:name Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens
53 schema:pagination 1816
54 schema:productId N0e6f50fc49d840f3bc0f1fe5e54e0ad8
55 N965f65977fcc49209252b4ada25ae34e
56 N9ca48ddf9ba2435998be68b5f84f6639
57 Nbaa39cc3e5de4b4398725dff63fc8040
58 Nd6c8e7aa47c6482d8acd88cc42091dff
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001585610
60 https://doi.org/10.1038/bjc.2011.178
61 schema:sdDatePublished 2019-04-11T00:05
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N98875675fc734fe4a7f8929c503485d2
64 schema:url https://www.nature.com/articles/bjc2011178
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N0e6f50fc49d840f3bc0f1fe5e54e0ad8 schema:name dimensions_id
69 schema:value pub.1001585610
70 rdf:type schema:PropertyValue
71 N1956d2e1cb4e4299a2ba243887f14ef8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Female
73 rdf:type schema:DefinedTerm
74 N1e7e78ce74404bd08daf9d39880065e8 schema:volumeNumber 104
75 rdf:type schema:PublicationVolume
76 N235d4da028d34ffbb51ae35ad4c9316f schema:name Department of Medical Oncology, Istituto Oncologico, via Hahnemann 10, Bari 70126, Italy
77 rdf:type schema:Organization
78 N24f838768acb4e8cb67794a177dc164b rdf:first sg:person.01076711104.26
79 rdf:rest N52d2e39a3dfd44d58dcc18a39525189b
80 N267fd9375e3345e1a2a81593c93d3441 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Humans
82 rdf:type schema:DefinedTerm
83 N28f4c1ef601e4699b9a7a1ac770e36a4 rdf:first sg:person.0605217455.41
84 rdf:rest rdf:nil
85 N29597efb10374118963ee880b1bef19e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Adult
87 rdf:type schema:DefinedTerm
88 N435c8b21c5da48b79dd5f263f6db2e9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Aged
90 rdf:type schema:DefinedTerm
91 N45ef374832264848985d53acb676b54c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Male
93 rdf:type schema:DefinedTerm
94 N5101bd1fcd5e4839a1f1e0ea4cbfac31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Middle Aged
96 rdf:type schema:DefinedTerm
97 N52d2e39a3dfd44d58dcc18a39525189b rdf:first sg:person.0666401714.46
98 rdf:rest Ne913c96ff1ec4992aa0b07ea639edd03
99 N543331d545ad461b9643a991c2bfb218 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Antineoplastic Combined Chemotherapy Protocols
101 rdf:type schema:DefinedTerm
102 N5fac4af7e04c4e559996237fd72b280e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Blood-Brain Barrier
104 rdf:type schema:DefinedTerm
105 N785fc6800d2841b39a763cc53fb3ffc1 rdf:first sg:person.0707026774.05
106 rdf:rest N24f838768acb4e8cb67794a177dc164b
107 N822605b998b64ff4a4bb9b15001338a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Brain Neoplasms
109 rdf:type schema:DefinedTerm
110 N8762388e07ca450b8a16fac91e2cf601 schema:name Department of Medical Oncology, Istituto Oncologico, via Hahnemann 10, Bari 70126, Italy
111 rdf:type schema:Organization
112 N965f65977fcc49209252b4ada25ae34e schema:name doi
113 schema:value 10.1038/bjc.2011.178
114 rdf:type schema:PropertyValue
115 N98875675fc734fe4a7f8929c503485d2 schema:name Springer Nature - SN SciGraph project
116 rdf:type schema:Organization
117 N9ca48ddf9ba2435998be68b5f84f6639 schema:name pubmed_id
118 schema:value 21610711
119 rdf:type schema:PropertyValue
120 Nad06d652ba344efb8b0ce310b2191989 rdf:first sg:person.0707113743.39
121 rdf:rest Nbac6a26d606a49f6ac284bee46801058
122 Nb8b964febe61474f9b3ddfbb7cd6b039 schema:issueNumber 12
123 rdf:type schema:PublicationIssue
124 Nbaa39cc3e5de4b4398725dff63fc8040 schema:name nlm_unique_id
125 schema:value 0370635
126 rdf:type schema:PropertyValue
127 Nbac6a26d606a49f6ac284bee46801058 rdf:first sg:person.01340562667.17
128 rdf:rest Ne2ab9fbce1334a32a3a069529748c4ab
129 Nc7613c7f136e4f25bf70239f674afbb9 rdf:first sg:person.01050453536.03
130 rdf:rest N28f4c1ef601e4699b9a7a1ac770e36a4
131 Nc9ce371b9d4e4c7680914f1c985e3568 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Skin Neoplasms
133 rdf:type schema:DefinedTerm
134 Ncd49ebdfede2432d9f1fa3b3fceda7fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Dacarbazine
136 rdf:type schema:DefinedTerm
137 Nd49fe60243984b28ae5f061841ae1a40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Melanoma
139 rdf:type schema:DefinedTerm
140 Nd6c8e7aa47c6482d8acd88cc42091dff schema:name readcube_id
141 schema:value 078da252aa71076760d36fb57d5eb0c389c32a72a98cd4524a80e104365348d4
142 rdf:type schema:PropertyValue
143 Ne2ab9fbce1334a32a3a069529748c4ab rdf:first sg:person.01163341772.34
144 rdf:rest Ne9322da25e104516b29b8338607e1fdb
145 Ne913c96ff1ec4992aa0b07ea639edd03 rdf:first sg:person.0634153206.02
146 rdf:rest Nc7613c7f136e4f25bf70239f674afbb9
147 Ne9322da25e104516b29b8338607e1fdb rdf:first sg:person.0764656474.81
148 rdf:rest N785fc6800d2841b39a763cc53fb3ffc1
149 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
150 schema:name Medical and Health Sciences
151 rdf:type schema:DefinedTerm
152 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
153 schema:name Oncology and Carcinogenesis
154 rdf:type schema:DefinedTerm
155 sg:journal.1017082 schema:issn 0007-0920
156 1532-1827
157 schema:name British Journal of Cancer
158 rdf:type schema:Periodical
159 sg:person.01050453536.03 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
160 schema:familyName Ridolfi
161 schema:givenName R
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050453536.03
163 rdf:type schema:Person
164 sg:person.01076711104.26 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
165 schema:familyName Pigozzo
166 schema:givenName J
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076711104.26
168 rdf:type schema:Person
169 sg:person.01163341772.34 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
170 schema:familyName Ridolfi
171 schema:givenName L
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163341772.34
173 rdf:type schema:Person
174 sg:person.01340562667.17 schema:affiliation N235d4da028d34ffbb51ae35ad4c9316f
175 schema:familyName Guida
176 schema:givenName M
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340562667.17
178 rdf:type schema:Person
179 sg:person.0605217455.41 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
180 schema:familyName De Salvo
181 schema:givenName G L
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605217455.41
183 rdf:type schema:Person
184 sg:person.0634153206.02 schema:affiliation N8762388e07ca450b8a16fac91e2cf601
185 schema:familyName Colucci
186 schema:givenName G
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634153206.02
188 rdf:type schema:Person
189 sg:person.0666401714.46 schema:affiliation https://www.grid.ac/institutes/grid.415176.0
190 schema:familyName Brugnara
191 schema:givenName S
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666401714.46
193 rdf:type schema:Person
194 sg:person.0707026774.05 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
195 schema:familyName Del Bianco
196 schema:givenName P
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707026774.05
198 rdf:type schema:Person
199 sg:person.0707113743.39 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
200 schema:familyName Chiarion-Sileni
201 schema:givenName V
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707113743.39
203 rdf:type schema:Person
204 sg:person.0764656474.81 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
205 schema:familyName Romanini
206 schema:givenName A
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764656474.81
208 rdf:type schema:Person
209 sg:pub.10.1007/s10147-008-0797-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037744453
210 https://doi.org/10.1007/s10147-008-0797-8
211 rdf:type schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1074500170 schema:CreativeWork
213 https://app.dimensions.ai/details/publication/pub.1074669606 schema:CreativeWork
214 https://app.dimensions.ai/details/publication/pub.1075173462 schema:CreativeWork
215 https://app.dimensions.ai/details/publication/pub.1077278318 schema:CreativeWork
216 https://app.dimensions.ai/details/publication/pub.1077917465 schema:CreativeWork
217 https://app.dimensions.ai/details/publication/pub.1082952799 schema:CreativeWork
218 https://doi.org/10.1002/cncr.11436 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030848636
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/annonc/mdi190 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050987641
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1097/00008390-200204000-00011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004158366
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1097/01.cmr.0000136711.75287.55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042572950
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1097/01.cmr.0000183921.46031.93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012826588
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1097/01.cmr.0000195697.58013.b7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004821277
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1097/01.coc.0000164006.72694.1b schema:sameAs https://app.dimensions.ai/details/publication/pub.1016084043
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1097/cmr.0b013e3283350578 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053462375
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1177/38.9.1974900 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031461172
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1179/joc.1995.7.3.224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044813084
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1200/jco.1999.17.7.2105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549817
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1200/jco.20.6.1600 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202886
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1200/jco.2000.18.1.158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074572226
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1200/jco.2001.19.16.3635 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074864907
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1200/jco.2002.07.044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203018
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1200/jco.2004.12.149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001105110
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1200/jco.2005.02.5791 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023297721
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1200/jco.2006.10.0677 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000033623
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1200/jco.2007.12.0253 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044938860
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1214/aos/1176350951 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010369076
257 rdf:type schema:CreativeWork
258 https://www.grid.ac/institutes/grid.144189.1 schema:alternateName Azienda Ospedaliera Universitaria Pisana
259 schema:name Medical Oncology Unit, S. Chiara Hospital, via Roma 67, Pisa 56100, Italy
260 rdf:type schema:Organization
261 https://www.grid.ac/institutes/grid.415176.0 schema:alternateName Ospedale Santa Chiara
262 schema:name Oncology Center, S. Chiara Hospital, Largo Medaglie d’Oro 1, Trento 38100, Italy
263 rdf:type schema:Organization
264 https://www.grid.ac/institutes/grid.419546.b schema:alternateName Istituto Oncologico Veneto
265 schema:name Clinical Trials and Biostatistics Unit, Istituto Oncologico Veneto IOV – IRCCS, via Gattamelata 64, Padova 35128, Italy
266 Melanoma and Skin Cancer Unit, Istituto Oncologico Veneto IOV – IRCCS, via Gattamelata 64, Padova 35128, Italy
267 rdf:type schema:Organization
268 https://www.grid.ac/institutes/grid.419563.c schema:alternateName Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
269 schema:name Immunotherapy and Somatic Cell Therapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, via Maroncelli 40, Meldola FC 47014, Italy
270 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...